What a Target Trial Emulation Reveals About GLP-1 Safety in Patients With Opiate Use Disorder
This large target trial emulation evaluated GLP-1 safety in opioid use disorder using national claims data. Investigators found no increased risk across ten gastrointestinal, psychiatric, respiratory, and renal outcomes. The findings provide important…
Cannabis and Testosterone: A Swiss Study Challenges Conventional Wisdom – Newsweed
✦ New CED Clinical Relevance #76 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchTHCSafetyAgingMental HealthNeurologyDosing Clinical Summary A recent Swiss study challenges the…
DOJ Reschedules Medical Marijuana; States Face New Uncertainty – KOTA
The DOJ medical marijuana rescheduling impact marks a pivotal federal policy shift. This change lowers research barriers and affects state medical cannabis programs. Patients and clinicians now face new legal uncertainties amid evolving regulations.
The Neuroscience Behind Cannabis Addiction and Misuse | Milford, CT Patch
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchTHCMental HealthSafetyAnxietyBrain Health Why This Matters Understanding the neurobiological…
Cannabis for Sleep and Pain: Why Not Both?
Many patients wonder whether they should use cannabis for sleep or pain management separately. The truth is that cannabis can effectively address both conditions simultaneously through its interaction with neuroreceptors. CED Clinic provides expert…
Medical Cannabis vs Recreational Use: A Physician’s Perspective
Understanding the distinction between medical cannabis vs recreational use is crucial for both patients and healthcare providers. Dr. Caplan explains how therapeutic cannabis differs from casual use in terms of dosing, strain selection, and treatment…
Medical Cannabis Quality Standards vs Street Cannabis Safety
Medical cannabis quality standards ensure patient safety through rigorous testing and pharmaceutical-grade production. Street cannabis lacks these safety protocols, potentially exposing patients to contaminants and inconsistent dosing. Understanding…
In the Mix: 4 More Articles — June 01, 2026
This digest covers mixed cannabis industry articles June 2026 with a focus on clinical relevance. The articles include cannabis stock market activity and federal rescheduling updates. Clinicians must navigate fragmented media coverage to find…
5 ‘Aggrieved Persons’ Sue Trump, DOJ Over Cannabis Rescheduling Order
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchSafetyDosingIndustryTHCCBD Why This Matters Clinicians need to monitor this lawsuit’s outcome…
Frankel Bill Passes to Allow Medical Cannabis Access for Terminally Ill in Hospitals
The medical cannabis access legislation removes barriers for terminally ill patients in hospitals. This law allows clinicians to recommend cannabis for symptom relief such as pain and nausea. It supports patient autonomy and improves end-of-life care…